Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 19 Neoplasm Metastasis 13 Melanoma 12 Nasopharyngeal Carcinoma 10 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 8 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Locally Advanced Rectal Cancer 6 Carcinoma, Renal Cell 6 Uterine Cervical Neoplasms 4 Recurrence 4 Lymphoma, Extranodal NK-T-Cell 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Nasopharyngeal Neoplasms 3 Glioblastoma 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Thyroid Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Stromal Tumors 2

Interventions

Leucovorin 2 Irinotecan 2 Fluorouracil 2 spartalizumab 1 camrelizumab 1 Radiosurgery 1 Oxaliplatin 1 Oncolytic Virotherapy 1 KD025 1 IFL protocol 1 Folfox protocol 1 Drug Therapy 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × CRC × spartalizumab × Clear all

NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡